CS 8958: Clinical Trials

2 trials of CS 8958, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1

Follow CS 8958: new trials by email Literature Review of CS 8958 trials Research Report on CS 8958

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza
Phase 1 / Phase 2TerminatedBiota Scientific Management Pty Ltd152013-11-012025-01-13
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo - Influenza
Phase 2CompletedBiota Scientific Management Pty Ltd6392013-05-012018-05-31

Conditions studied

Influenza, Human (2)

Sponsors

Biota Scientific Management Pty Ltd (2)

Countries

United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Colombia (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Peru (1)  ·  South Africa (1)

Top investigators

John Lambert, PhD (1)  ·  Jolanta Airey, Dr (1)